title: Recurrent infection with Pseudomonas aeruginosa during eculizumab therapy in an allogeneic hematopoietic stem cell transplant recipient.
authors.affiliation: Division of Epidemiology and Infectious Diseases, Intermountain Healthcare, Salt Lake City, Utah, USA.
authors.forename: B J
authors.initials: BJ
authors.lastname: Webb
authors.affiliation: Intermountain Blood and Marrow Transplant Program, LDS Hospital, Salt Lake City, Utah, USA.
authors.forename: R
authors.initials: R
authors.lastname: Healy
authors.affiliation: Intermountain Blood and Marrow Transplant Program, LDS Hospital, Salt Lake City, Utah, USA.
authors.forename: B
authors.initials: B
authors.lastname: Child
authors.affiliation: Intermountain Blood and Marrow Transplant Program, LDS Hospital, Salt Lake City, Utah, USA.
authors.forename: J
authors.initials: J
authors.lastname: Majers
authors.affiliation: Nephrology Associates, Intermountain Medical Center, Salt Lake City, Utah, USA.
authors.forename: S
authors.initials: S
authors.lastname: Anand
authors.affiliation: Intermountain Blood and Marrow Transplant Program, LDS Hospital, Salt Lake City, Utah, USA.
authors.forename: L
authors.initials: L
authors.lastname: Gouw
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use*; D065766:Atypical Hemolytic Uremic Syndrome / Q000188:drug therapy / Q000209:etiology; D017809:Fatal Outcome; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D018410:Pneumonia, Bacterial / Q000382:microbiology*; D011552:Pseudomonas Infections / Q000382:microbiology*; D011550:Pseudomonas aeruginosa
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C481642:eculizumab
keywords: Pseudomonas aeruginosa; complement; eculizumab; hematopoietic stem cell transplant